Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 13/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.52 |
| ▸ | HTT | P42858 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | CDC25B | P30305 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 6/20 | 0.47 |
| ▸ | RAB9A | P51151 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | THRB | P10828 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 3/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19807223 | 0.78 | MAPT (0.39) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL14431153 | 0.73 | MAPT (0.58) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL1104624 | 0.73 | MAPT (0.58) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL23095433 | 0.70 | MAPT (0.54) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL1100511 | 0.70 | MAPT (0.54) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL10600278 | 0.69 | KMT2A (0.55) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL13678920 | 0.69 | KMT2A (0.55) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| Anthraquinone SCHEMBL5958714 | 0.68 | CDC25B (0.86) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL10633649 | 0.68 | MAPT (0.52) | MAPTALDH1A1HTTSMN1; SMN2HIF1A | |
| SCHEMBL14255693 | 0.68 | MAPT (0.54) | MAPTALDH1A1HTTSMN1; SMN2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756276-B2 | Organic photodiode and organic image sensor including the same | LG CHEM, LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20200194680-A1 | ORGANIC PHOTODIODE AND ORGANIC IMAGE SENSOR INCLUDING THE SAME | LG CHEM, LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
| US-20200066992-A1 | PHOTOACTIVE LAYER AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-27 | — | — | US | disclosed |
| US-20180026200-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20160372680-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160372680-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING THE SAME | SUN2, CRY1, STOM | MAPT 2108/4885ALDH1A1 1187/4885HTT 1590/4885 |
| US-20180026200-A1 | HETEROCYCLIC COMPOUND AND ORGANIC SOLAR CELL COMPRISING SAME | SUN2, CRY1, STOM | MAPT 2206/4885ALDH1A1 1159/4885HTT 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.